Managing clinical trial supply chains presents significant challenges, particularly for early-phase biotech and pharmaceutical companies with limited in-house resources and expertise. Here we present solutions to the most pressing challenges.

When a biotech developing cancer vaccines needed to enter Phase I clinical trials, standard labeling methods simply wouldn't hold - not at -80°C. PRONAV Clinical designed and qualified a bespoke manual labeling process capable of maintaining adhesion at ultra-low temperatures, ensuring compliant, reliable supply of the IMP to global clinical sites.